全文获取类型
收费全文 | 530篇 |
免费 | 39篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 15篇 |
妇产科学 | 14篇 |
基础医学 | 99篇 |
口腔科学 | 25篇 |
临床医学 | 38篇 |
内科学 | 124篇 |
皮肤病学 | 12篇 |
神经病学 | 52篇 |
特种医学 | 23篇 |
外科学 | 40篇 |
综合类 | 5篇 |
一般理论 | 1篇 |
预防医学 | 33篇 |
眼科学 | 5篇 |
药学 | 37篇 |
中国医学 | 2篇 |
肿瘤学 | 44篇 |
出版年
2024年 | 3篇 |
2021年 | 14篇 |
2020年 | 6篇 |
2019年 | 18篇 |
2018年 | 18篇 |
2017年 | 13篇 |
2016年 | 7篇 |
2015年 | 5篇 |
2014年 | 10篇 |
2013年 | 24篇 |
2012年 | 29篇 |
2011年 | 27篇 |
2010年 | 21篇 |
2009年 | 22篇 |
2008年 | 28篇 |
2007年 | 25篇 |
2006年 | 18篇 |
2005年 | 24篇 |
2004年 | 17篇 |
2003年 | 26篇 |
2002年 | 18篇 |
2001年 | 10篇 |
2000年 | 18篇 |
1999年 | 9篇 |
1998年 | 18篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 5篇 |
1993年 | 7篇 |
1992年 | 4篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1985年 | 5篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1976年 | 7篇 |
1974年 | 6篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1968年 | 2篇 |
1967年 | 6篇 |
1966年 | 5篇 |
1965年 | 3篇 |
排序方式: 共有570条查询结果,搜索用时 31 毫秒
561.
Boza C Muñoz R Salinas J Gamboa C Klaassen J Escalona A Pérez G Ibañez L Guzmán S 《Obesity surgery》2011,21(9):1330-1336
The efficacy of Roux-en-Y gastric bypass (RYGB) to control type 2 diabetes mellitus (T2DM) has been demonstrated in morbidly
obese patients. Surgical procedures primarily focused on T2DM control in patients with body mass index (BMI) < 35 kg/m2 have shown to effectively induce remission of T2DM. However, only few reports have evaluated the safety and efficacy of RYGB
in this group of patients. The aim of this study is to assess the safety and efficacy of RYGB in TD2M patients with BMI < 35 kg/m2. All T2DM patients with BMI < 35 kg/m2 and at least 12 months of follow-up who underwent laparoscopic RYGB were included. Safety of the procedure was evaluated
according to mortality, need of reoperation/conversion, and complication rates. Metabolic parameters were evaluated at baseline
and 6, 12, and 24 months after surgery. Thirty patients were included. Seventeen (56.6%) were women. Age, BMI, and duration
of diabetes were 48 ± 9 years, 33.7 ± 1.2 kg/m2, 4 ± 2.9 years, respectively. No mortality was observed. No conversion/reoperation was needed. Average length of stay was
3.2 ± 0.9 days. Early and late postoperative complications were observed in five (16.6%) and five (16.6%) patients, respectively.
Twelve months after surgery, remission was observed in 25 of 30 patients (83.3%). After 2 years, remission was achieved in
13 of 20 patients (65%), and hemoglobin A1c decreased from 8.1 ± 1.8% to 5.9 ± 1.1% and homeostasis model assessment of insulin
resistance from 5.7 ± 3.2 to 1.9 ± 0.8 after 12 months. RYGB is a safe and effective procedure to induce T2DM remission in
otherwise not eligible patients for bariatric surgery. Evidence from prospective studies is needed to validate this approach. 相似文献
562.
563.
Argentine hemorrhagic fever (AHF), an acute disease caused by Junin virus (JUNV, Arenaviridae), has been an important issue to public health in Argentina since the early 1950s. The field rodent Calomys musculinus is JUNV natural reservoir and human disease is a consequence of contact with infected rodents. A steady extention of AHF endemic area is being observed since the first reports of the disease. Important achievements have been made in: (a) improvement of methods for the etiological diagnosis; (b) implementation and validation of therapeutical measures; (c) development of vaccines to protect against AHF. Reference is made to different research strategies used to obtain anti-AHF vaccines in the past and anti-arenaviral diseases in the present. Information is updated on features and field performance of Candid #1 vaccine, a live attenuted vaccine currently used to prevent AHF. This vaccine was developed through a joint international effort that envisioned it as an orphan drug. With transferred technology, Argentine government was committed to be Candid #1 manufacturer and to register this vaccine as a novel medical product under the Argentine regulatory authority. Candid #1 vaccine is the first one used to control an arenaviral hemorrhagic fever, the first live viral vaccine to be manufactured and registered in Argentina, reaching its target population through governmental effort. 相似文献
564.
Tordesillas L Gamboa P Sanz ML Palacín A Gómez-Casado C Cuesta-Herranz J Pacios LF Salcedo G Díaz-Perales A 《Molecular immunology》2011,49(3):504-511
Hypoallergenic mutants with reduced IgE-binding capacity but which show a similar T-cell response to the corresponding natural allergen are ideal tools for immunotherapy, for preventing a possible anaphylactic shock. An IgE conformational epitope has been identified in Cuc m 2, the major allergen and profilin from melon. Since this epitope is highly conserved in most pollen profilins, it may contribute to an explanation of cross-reactivity between pollen and food profilins. Mutants (Mut 1 and Mut 2) were generated by changing specific residues of the Cuc m 2 epitope to alanine, produced in Escherichia coli, and purified by chromatographic methods. Mut 1 showed a slight reduction in IgE binding but an allergenic activity that was similar to recombinant Cuc m 2, as measured by basophil activation test (BAT) and skin prick test (SPT). By contrast, Mut 2 displayed a substantial reduction in IgE-binding capacity (57%) and positive responses, as determined by BAT (33%) and SPT (50%), when compared to those of rCuc m 2. However, the T-cell proliferation and cytokine production induced by Mut 2 and rCuc m 2 were similar. Thus, this mutant represent potential candidate for immunotherapy of profilin allergies. 相似文献
565.
F Alcántara-González CR Mendoza-Perez N Zaragoza I Juarez LE Arroyo-García C Gamboa F De La Cruz S Zamudio F Garcia-Dolores G Flores 《Synapse (New York, N.Y.)》2012,66(11):938-949
Cerebrolysin (Cbl) shows neurotrophic and neuroprotective properties while donepezil (Dnp) is a potent acetylcholinesterase (AChE) inhibitor, both drugs are prescribed for Alzheimer's disease (AD) treatment. Previous studies have shown that the Dnp and Cbl administered separately, modify dendritic morphology of neurons in the prefrontal cortex and hippocampus in senile rodents. Since the deficit of neurotrophic factor activity is implicated in the degeneration of cholinergic neurons of basal forebrain, a combination therapy of Dnp and Cbl has been tested recently in Alzheimer's patients. However, the plastic changes that may underlie this combined treatment have not yet been explored. We present here the effect of the combined administration of Cbl and Dnp on dendritic morphology in brain regions related to learning and memory in aged mice. The Golgi‐Cox staining protocol and Sholl analysis were used for studying dendritic changes. Cbl and Dnp were administrated daily for 2 months to 9‐months‐old mice. Locomotor activity was assessed, as well as the dendritic morphology of neurons in several limbic regions was analyzed. Results showed that Cbl and Dnp induced an increase in locomotor activity without synergistic effect. The Cbl or Dnp treatment modified the dendritic morphology of neurons from prefrontal cortex (PFC), dorsal hippocampus (DH), dentate gyrus (DG), and the shell of nucleus accumbens (NAcc). These changes show an increase in the total dendritic length and spine density, resulting in an improvement of dendritic arborization. Prominently, a synergistic effect of Cbl and Dnp was observed on branching order and total dendritic length of pyramidal neurons from PFC. These results suggest that Dnp and Cbl may induce plastic changes in a manner independent of each other, but could enhance their effect in target cells from PFC. Synapse 66:938–949, 2012. © 2012 Wiley Periodicals, Inc. 相似文献
566.
Ingelmo PM Gelsumino C Acosta AP Lopez V Gimenez C Halac A Lira P Schon A Spagnolo B Pignataro A Nunez G Gamboa M Buquicchio I Astuto M Fumagalli R 《Minerva anestesiologica》2007,73(11):575-585
BACKGROUND: The goal of the present work is to describe the development and results of the pediatric epidural analgesia program at the 'Hospital Nacional de Pediatria Prof. Dr. J. P. Garrahan' in Argentina. METHODS: Patients with thoracotomy, abdominal surgery, osteotomy, amputations or severe trauma were included in the program. The program provided training to the entire staff, control and record of pain treatment and its consequences, 24 h a day availability of anesthesia staff and standard polices and procedures. RESULTS: One hundred fifty children under 16 years of age (median age 11 years, median weight 35 kg) were included in the program during the first 18 months. The median of maximum pain reported during activity was 1 (interquartile range 1 to 4 points) using the Visual Analogue Scale (VAS) or Objective Pain Scale (OPS). Eighty seven children (CI 95% 50% to 67%) presented with postoperative nausea and vomiting, urinary retention, itching, motor blockade or sedation. No patient presented with respiratory depression, hypotension, local anaesthetic toxicity, epidural catheter related infection or death during the program evaluation. The postoperative care program enabled a 98-day reduction in treatment in the intensive care unit. CONCLUSION: The safe use of pediatric epidural analgesia in general wards may require the careful selection of patients, systematic assessment by trained personnel, training of medical and nursing personnel, clear distribution of responsibilities, use of printed indications, systematic record of pain, sedation and complications, information and education of patients and parents, supply of systems for airway resuscitation and management and continuous quality control and revision of the methods. 相似文献
567.
Gamboa R Mollón FP Ríos-Méndez RE Arroyo GM Fogel A Villa DM 《Revista espa?ola de cardiología》2007,60(4):445-448
Between May 2003 and July 2006, we carried out percutaneous patent ductus arteriosus closure using a Nit-Occlud device in 28 patients, who had a median age of 1.8 years (range 0.5-21 years) and a median weight of 10.9 kg (range 5.9-64 kg). The ductus arteriosus had several different morphologic forms, and there was one postsurgical recanalization of the ductus arteriosus. The median minimum ductal diameter was 1.8 mm and the median maximum aortic ampulla diameter was 6.5 mm. The occlusion rate immediately after intervention was 53.5%, which increased to 95.2% by 12 months and to 100% by 18 months. The median follow-up time was 20.5 months. The Nit-Occlud device provided an effective and safe means of patent ductus arteriosus closure, irrespective of ductus morphology. 相似文献
568.
Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508
Janet Stiernberg PhD ; Andrea M. Norfleet PhD ; William R. Redin BS ; W. Scott Warner MD ; Richard R. Fritz PhD ; Darrell H. Carney PhD ET AL. 《Wound repair and regeneration》2000,8(3):204-215
Thrombin is an essential factor in hemostasis, inflammation, and tissue repair. The synthetic thrombin peptide, TP508, binds to high-affinity thrombin receptors and mimics cellular effects of thrombin at sites of tissue injury. Treatment of full-thickness excisional wounds in normal rats with a single topical application of 0.1 microg TP508 (14 pmol/cm2) reproducibly accelerates wound closure, yielding wounds that on average close 39% more than controls by day 7 (p < 0.001). Wounds treated with 1.0 microg TP508 are 35% and 43% (p < 0.001) smaller than controls on day 7 and 10, respectively. The early rate of closure is approximately 40% greater in TP508-treated than vehicle-treated wounds (20 versus 14 mm2/day) and remains higher through day 7. Breaking strength after closure is slightly greater (15-23%) in wounds treated with TP508 than with saline alone. Histologic comparisons show that TP508 enhances recruitment of inflammatory cells to the wound site within 24 hours post-injury. TP508 treatment also augments revascularization of injured tissue, as evidenced at day 7 by the larger size of functional vessels in the granulation tissue and by the directed development of blood vessels to wounds. These studies raise the possibility that TP508 may be clinically useful in management of open wounds. 相似文献
569.
570.